Phibro Animal Health Corporation (PAHC) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $34.89 (+1.29%), Market cap $1.36B, P/E ratio 14.36, 52-week low–high $23.02 ~ $59.58.
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufac
Financial statements, price targets, institutional (13F) holdings and related news for Phibro Animal Health Corporation are updated in real time on BlackAll Trade.
Phibro Animal Health Corporation trades at $34.89 (+1.29%). Real-time quotes and charts are available on BlackAll Trade.
Phibro Animal Health Corporation has a market cap of about $1.36B. Its P/E ratio is 14.36.
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It op